ClinicalTrials.Veeva

Menu

SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification (MAG-NODE)

R

Radboud University Medical Center

Status

Unknown

Conditions

Head and Neck Squamous Cell Carcinoma

Treatments

Diagnostic Test: SPIO-enhanced MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT04803331
MAG-NODE study

Details and patient eligibility

About

To explore the feasibility of sentinel lymph node identification by SPIO injection followed by MRI in head-and-neck cancer patients.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female aged >18 years.
  • Patients with histopathologically proven cT1-2N0M0 squamous cell carcinoma of the oral cavity.
  • Patients planned to undergo routine sentinel node biopsy with 99mTc-radioisotope and SPECT-CT.
  • Patient provided written informed consent.

Exclusion criteria

  • Patients who underwent previous surgery or radiotherapy to the neck.
  • Contra-indications to SPIO (Hypersensitivity to iron oxide or dextran compounds, Presence of iron overload disease (hereditary hemochromatosis, hemosiderosis, chronic hemolytic anemia (e.g. thalassemia, sickle cell anemia))
  • Contra-indications to MRI: Epilepsy, Claustrophobia, Metallic splinters, Pacemaker, pacemaker wires or implanted defibrillator, Implanted magnets in jaw, Metallic Arterial clips (carotid arteries), Pregnancy, Auditory implant, neurogenic bladder stimulator, insulin pump, neurostimulator, baclofen pump, Metallic tissue expander after mastectomy, Cochlear implant, Metallic braces, Other foreign bodies implanted
  • Unable to provide informed consent.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

cT1-2N0M0 oral cancer patients
Experimental group
Description:
Patients undergo routine sentinel lymph node procedure (99mTc injection, planar imaging, SPECT-CT and surgery) for clinical purposes. After 99mTc injections and imaging has been executed peritumoral SPIO injections are performed by a medical doctor. A T2\*-weighted iron sensitive MRI scan is made 1 hour later.
Treatment:
Diagnostic Test: SPIO-enhanced MRI

Trial contacts and locations

1

Loading...

Central trial contact

D.A.J.J. Driessen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems